TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03721120 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03721120 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03721120 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03721120 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03721120 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT03721120 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03721120 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01502397 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01527487 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04182568 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01655485 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03608176 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03981614 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03981614 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03981614 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03758053 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03212742 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT03212742 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04860947 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT01314586 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04574934 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04561024 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00013533 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00013533 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00013533 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03957564 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03957564 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02829840 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00605397 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00619073 — Predictive Biomarker (PRD): PRKRA mRNA
Genes: PRKRA; PACT; RAX; HSD-14; HSD14
Study NCT00005204 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02152553 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT04681755 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03505281 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT03505281 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03505281 — Predictive Biomarker (PRD): VCAM1 mRNA
Genes: VCAM1
Study NCT01741519 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01741519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01910168 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT02733016 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00501917 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04335006 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00078585 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02070536 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT01200732 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00658385 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT00658385 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02582775 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00525655 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT00303862 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00209430 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00088374 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT00001386 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00204178 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01508572 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04396756 — Predictive Biomarker (PRD): PLN mRNA
Genes: PLN; PLB
Study NCT00005941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04503278 — Predictive Biomarker (PRD): CLDN6 mRNA
Genes: CLDN6; UNQ757/PRO1488
Study NCT03506152 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03506152 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00157677 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02390531 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00069498 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02358642 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03510650 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT04649918 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03890861 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03890861 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04595565 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04595565 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04595565 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03514121 — Predictive Biomarker (PRD): VTCN1 mRNA
Genes: VTCN1; B7H4; UNQ659/PRO1291
Study NCT03514121 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04464200 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00545454 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00545454 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04248426 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03559608 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03962543 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03109964 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02151266 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02151266 — Safety Biomarker (SAF): BDNF
Study NCT04308980 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04363372 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT03310788 — Predictive Biomarker (PRD): PHEX mRNA
Genes: PHEX; PEX
Study NCT03595683 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02400567 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT02654444 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04248439 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study NCT01988493 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02433652 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00639158 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00639158 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01535391 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01535391 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01741428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03147859 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02341183 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT00815659 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03343197 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03343197 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study NCT01349920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01778361 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00812279 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT01458470 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04167605 — Predictive Biomarker (PRD): SENP1 mRNA
Genes: SENP1
Study NCT01185067 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01276522 — Safety Biomarker (SAF): Interleukin 1
Study NCT00393692 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05069246 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05069246 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT02131259 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00093041 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03837223 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00559507 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02289222 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03598673 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02372955 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02726568 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02194660 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03665961 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03665961 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04284228 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT04284228 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT02874807 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02874807 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02874807 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01469169 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02933749 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03735264 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01740115 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04602884 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01703234 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01703234 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04382040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03739268 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03739268 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT03739268 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT01635153 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02707692 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04800809 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01877993 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04577521 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00996918 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03405246 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02644655 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00630448 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04603599 — Predictive Biomarker (PRD): L1CAM mRNA
Genes: L1CAM; CAML1; MIC5
Study NCT05220527 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04636684 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT04671849 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04671849 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04671849 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT04671849 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT04671849 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT03997409 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03554473 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT03554473 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT03554473 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCNE1 mRNA
Genes: CCNE1; CCNE
Study NCT03554473 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03554473 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT00856921 — Predictive Biomarker (PRD): AAAS mRNA
Genes: AAAS; ADRACALA; GL003
Study NCT00361296 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03443674 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT04319081 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03866135 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01703013 — Predictive Biomarker (PRD): DEFA4 mRNA
Genes: DEFA4; DEF4
Study NCT03635385 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT00688311 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04971876 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00391092 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00655031 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00015977 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00015977 — Safety Biomarker (SAF): Interleukin 12
Study NCT04481035 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04501783 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00059462 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03839771 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03839771 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT02644590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01975259 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01975259 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01746199 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04024280 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01094132 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02888600 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02874378 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT03445234 — Predictive Biomarker (PRD): S100A8 mRNA
Genes: S100A8; CAGA; CFAG; MRP8
Study NCT03445234 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study NCT01855854 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00500084 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01024413 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03439865 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01768845 — Predictive Biomarker (PRD): UBC mRNA
Genes: UBC
Study NCT01150409 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04042922 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02330432 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT00182728 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02129699 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT03203408 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00227734 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03250715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03250715 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT01550068 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT04363775 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04242082 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study NCT00083941 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00940680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00033137 — Predictive Biomarker (PRD): FLCN mRNA
Genes: FLCN; BHD
Study NCT00896922 — Predictive Biomarker (PRD): IRF4 mRNA
Genes: IRF4; MUM1
Study NCT03183193 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04327804 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03834233 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04139057 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04139057 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02863510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00520364 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00910793 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04053010 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00082017 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT01565070 — Predictive Biomarker (PRD): TRPM8 mRNA
Genes: TRPM8; LTRPC6; TRPP8
Study NCT00577252 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03227263 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04475367 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00342810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04594499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04660318 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04690725 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04690725 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00004259 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05826028 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03134872 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00863252 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02666573 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02666573 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT02199080 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00380575 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT00380575 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04160507 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT00446511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03925285 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03925285 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04359186 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02624817 — Predictive Biomarker (PRD): KCNJ11 mRNA
Genes: KCNJ11
Study NCT02202200 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT04094831 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02930824 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01649232 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study NCT02955394 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01819701 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04567160 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02314949 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00719758 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT02298595 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03582774 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02663388 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03024476 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03344965 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03344965 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04295447 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT01385787 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT02109484 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01644734 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT01391546 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03421483 — Predictive Biomarker (PRD): SLC46A1 mRNA
Genes: SLC46A1; G21; HCP1; PCFT
Study NCT03421483 — Predictive Biomarker (PRD): GGH mRNA
Genes: GGH
Study NCT03421483 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04279717 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01100801 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02641782 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02641782 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05193110 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05193110 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT02364089 — Surrogate Endpoint (SUR): Blood pressure